Learn more

CHIRON BEHRING GMBH & CO

Overview
  • Total Patents
    84
About

CHIRON BEHRING GMBH & CO has a total of 84 patent applications. Its first patent ever was published in 1988. It filed its patents most often in Japan, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are AERAS GLOBAL TB VACCINE FOUNDATION, NATIONWIDE CHILDRENS HOSPITAL and HIPRA LAB SA.

Patent filings per year

Chart showing CHIRON BEHRING GMBH & COs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Hundt Erika 15
#2 Knapp Bernhard 15
#3 Vorlop Juergen 14
#4 Frech Christian 12
#5 Gregersen Jens-Peter 11
#6 Groener Albrecht 11
#7 Vorlop Jurgen 8
#8 Luebben Holger 7
#9 Domdey Horst 7
#10 Von Specht Bernd-Ulrich 6

Latest patents

Publication Filing date Title
GB0601733D0 Vaccines
CA2583221A1 Combination vaccine
GB0514053D0 Rabies vaccine with reduced antigen dose
EP1702636A1 Syringe accessory device
US2005063987A1 Proteins, in particular membrane proteins, of Helicobacter pylori, their preparation and use
AU2002347030A1 Cultivation of dispersed mycobacteria
DE10144903A1 Replication of virus in cell cultures, useful for preparing vaccines and diagnostic reagents, where replication of cells and virus is simultaneous
DE10012370A1 Use of oil-in-water emulsion as vaccine adjuvant, particularly for influenza and pneumococcal vaccines, administered at different site from the vaccine
DE19847628A1 Helicobacter pylori vaccine
DE19847074C1 Process for the removal of lipopolysaccharides from aqueous, protein-containing solutions
CA2250714A1 Animal cells and processes for the replication of influenza viruses
DE19630390A1 Proteins, in particular membrane proteins from Helicobacter pylori, their production and use
EP0717106A1 Immunogenic hybrid protein OprF-Oprl derived from Pseudomonas aeruginosa membrane proteins
DE4232073A1 Method for the immunochemical quantification of inactivated, immunoreactive antigens